Imbria Pharmaceuticals, Inc.
Pharmaceutical company · Boston, Massachusetts, United States
Imbria Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2018. It has reported private securities offerings to the US SEC, most recently $67 million sold in a notice filed in 2025.
Imbria Pharmaceuticals at a glance
What does Imbria Pharmaceuticals do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $66.7 million sold (2025).
Frequently asked questions about Imbria Pharmaceuticals
Where is Imbria Pharmaceuticals headquartered?
Imbria Pharmaceuticals, Inc. is headquartered in Boston, Massachusetts, United States.
What does Imbria Pharmaceuticals do?
Imbria Pharmaceuticals, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
When was Imbria Pharmaceuticals founded?
The earliest incorporation on record for Imbria Pharmaceuticals, Inc. is in 2018, according to public company registers.
Similar companies
- Transcode Therapeutics, Inc.Boston, Massachusetts, United States
- Akouos, Inc.Boston, Massachusetts, United States
- Astria Therapeutics, Inc.Boston, Massachusetts, United States
- Albireo Pharma, Inc.Boston, Massachusetts, United States
- Atea Pharmaceuticals, Inc.Boston, Massachusetts, United States
- Rhythm Pharmaceuticals, Inc.Boston, Massachusetts, United States
- Tango Therapeutics, Inc.Boston, Massachusetts, United States
- Paratek Pharmaceuticals, Inc.Boston, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences